169 related articles for article (PubMed ID: 32312951)
1. Measurement and models accounting for cell death capture hidden variation in compound response.
Bae SY; Guan N; Yan R; Warner K; Taylor SD; Meyer AS
Cell Death Dis; 2020 Apr; 11(4):255. PubMed ID: 32312951
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells.
Kasukabe T; Honma Y; Okabe-Kado J; Higuchi Y; Kato N; Kumakura S
Oncol Rep; 2016 Aug; 36(2):968-76. PubMed ID: 27375275
[TBL] [Abstract][Full Text] [Related]
3. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
[TBL] [Abstract][Full Text] [Related]
4. Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
Lee MH; Hong SH; Park C; Kim GY; Leem SH; Choi SH; Keum YS; Hyun JW; Kwon TK; Hong SH; Choi YH
Oncol Rep; 2016 Jul; 36(1):205-14. PubMed ID: 27221553
[TBL] [Abstract][Full Text] [Related]
5. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes.
Ercan A; Oncul S; Karakaya G; Aytemir M
Bioorg Chem; 2020 Dec; 105():104403. PubMed ID: 33166845
[TBL] [Abstract][Full Text] [Related]
6. Sanggenol L promotes apoptotic cell death in melanoma skin cancer cells through activation of caspase cascades and apoptosis-inducing factor.
Won YS; Seo KI
Food Chem Toxicol; 2020 Apr; 138():111221. PubMed ID: 32084496
[TBL] [Abstract][Full Text] [Related]
7. A new acetylacetone derivative inhibits breast cancer by apoptosis induction and angiogenesis inhibition.
Talib WH; Al-Noaimi M; Alsultan ES; Bader R; Qnais E
J Cancer Res Ther; 2019; 15(5):1141-1146. PubMed ID: 31603124
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.
Hussain A; Mohsin J; Prabhu SA; Begum S; Nusri Qel-A; Harish G; Javed E; Khan MA; Sharma C
Asian Pac J Cancer Prev; 2013; 14(10):5855-60. PubMed ID: 24289589
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
10. Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines.
Karabulut B; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Uslu R
Mol Biol Rep; 2011 Jan; 38(1):249-59. PubMed ID: 20349282
[TBL] [Abstract][Full Text] [Related]
11. Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.
Moraya AI; Ali JL; Samadder P; Liang L; Morrison LC; Werbowetski-Ogilvie TE; Ogunsina M; Schweizer F; Arthur G; Nachtigal MW
J Exp Clin Cancer Res; 2017 May; 36(1):67. PubMed ID: 28499442
[TBL] [Abstract][Full Text] [Related]
12. Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells.
Kim IH; Kwon MJ; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):4116-4122. PubMed ID: 28487956
[TBL] [Abstract][Full Text] [Related]
13. Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines.
Otahal A; Aydemir D; Tomasich E; Minichsdorfer C
Sci Rep; 2020 Jan; 10(1):959. PubMed ID: 31969600
[TBL] [Abstract][Full Text] [Related]
14. Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
Engesæter B; Engebraaten O; Flørenes VA; Mælandsmo GM
PLoS One; 2012; 7(9):e45492. PubMed ID: 23029050
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
16. New potential antiproliferative monophosphoester 2-aminoethyl dihydrogen phosphate in K-562 and K-562 MDR
Conceição TO; Cabral L; Laveli-Silva MG; Pacheco JC; Alves MG; Rabelo DC; Laiso R; Maria DA
Biomed Pharmacother; 2021 Oct; 142():112054. PubMed ID: 34463267
[TBL] [Abstract][Full Text] [Related]
17. Isothiouronium salts reduce NRAS expression, induce apoptosis and decrease invasion of melanoma cells.
Cisilotto J; Ferreira M; Filippin-Monteiro FB; Bortoluzzi AJ; Sa MM; Creczynski-Pasa TB
Anticancer Agents Med Chem; 2015; 15(3):353-62. PubMed ID: 25469513
[TBL] [Abstract][Full Text] [Related]
18. Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds.
Crochiere M; Kashyap T; Kalid O; Shechter S; Klebanov B; Senapedis W; Saint-Martin JR; Landesman Y
BMC Cancer; 2015 Nov; 15():910. PubMed ID: 26573568
[TBL] [Abstract][Full Text] [Related]
19. Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.
Faversani A; Vaira V; Moro GP; Tosi D; Lopergolo A; Schultz DC; Rivadeneira D; Altieri DC; Bosari S
Breast Cancer Res; 2014 May; 16(3):R55. PubMed ID: 24886669
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis.
Koshibu-Koizumi J; Akazawa M; Iwamoto T; Takasaki M; Mizuno F; Kobayashi R; Abe A; Tomoda A; Hamatake M; Ishida R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):363-8. PubMed ID: 12136250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
